MedTrace Logo

OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS

NCT03236740 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2018-03-20

No results posted yet for this study

Summary

This study is undertaken to compare the effects of treatment with commonly used OCP containing ethinylestradiol-cyproterone acetate and metformin in women with PCOS. Special attention will be paid to changes in ovarian stromal blood flow by using Color Doppler and they will be correlated with changes in hormonal parameters post-treatment.

Conditions

  • PCOS

Interventions

DRUG

Ethinyl Estradiol-cyprosterone acetate

Ethinyl Estradiol-cyprosterone acetate in the form of OCPs will be taken cyclically by the participants.

DRUG

Metformin Hydrochloride

Metformin Hydrochoride in the form of 500 mg tablets will be taken twice daily by participants.

Sponsors & Collaborators

  • S.C.B. Medical College and Hospital

    lead OTHER

Principal Investigators

  • Priyadarshini Tripathy, MD · SCB Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-03-01
Completion
2018-03-15

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03236740 on ClinicalTrials.gov